Efficacy of steroid therapy for pacing failure in a patient with chronic myocarditis

Internal Medicine

Volumn 43, Issue 3, 2004, Pages 213-217

  Mitsuya, Nobuyuki ^a   Kishi, Ryoji ^a   Suzuki, Noriyuki ^a   Tamura, Masachika ^a   Imai, Yukiko ^a   Tanaka, Osamu ^a   Takagi, Akihiko ^a   Nakazawa, Kiyoshi ^a   Miyake, Fumihiko ^a   Nobuoka, Sachihiko ^a   Koike, Jyunki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic myocarditis; Pacing failure; Steroid therapy

Indexed keywords

CARDIAC MYOSIN; CORTICOSTEROID; CREATINE KINASE ISOENZYME; CREATININE; METHYLPREDNISOLONE; MYOSIN LIGHT CHAIN; PREDNISOLONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CHRONIC DISEASE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG EFFICACY; DYSPNEA; ENDOCARDIAL BIOPSY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE PACING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEG EDEMA; MALE; MYOCARDITIS; PACEMAKER FAILURE; SICK SINUS SYNDROME; STEROID THERAPY;

AGED; CARDIAC PACING, ARTIFICIAL; CHRONIC DISEASE; CREATINE KINASE; DISEASE PROGRESSION; FIBROSIS; GLUCOCORTICOIDS; HEART VENTRICLES; HUMANS; MALE; METHYLPREDNISOLONE; MYOCARDITIS; MYOCARDIUM; PEPTIDE FRAGMENTS; PREDNISOLONE; PROCOLLAGEN; SICK SINUS SYNDROME; TREATMENT FAILURE; VENTRICULAR FUNCTION, LEFT;

EID: 11144357259     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.213     Document Type: Article

References (14)

1. Hanawa H, Izumi T, Kodama M, et al. Chronic myocarditis and steroid therapy. Heart 24: 719-723, 1992 (in Japanese).
2. Juhl U, Strauer BE, Schultheiss HP. Methylprednisolone in chronic myocarditis. Postgrad Med J 70 Suppl 1: S35-S42, 1994.
3. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333: 269-275, 1995.
4. Toyozaki T, Hiroe M. The inflammatory process in chronic myocarditis. Respiration & circulation 46: 443-449, 1998 (in Japanese).
5. Kishimoto C. Therapy with Immunoglobulin in myocarditis and acute inflammatory cardiomyopathy. Heart 33: 511-517, 2001 (in Japanese).
6. Arima M, Kanoh T, Kawano Y, et al. Recurrence of myocarditis presenting as pacing and sensing failure after implantation of a permanent pacemaker at first onset. Jpn Circ 165: 345-348, 2001.
7. Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. N Engl J Med 330: 1129-1135, 1994.
8. Japanese Circulation Society (JCS) Task Force Committee on Chronic Myocarditis. Guideline for diagnosing chronic myocarditis. Jpn Circ J 60: 263-264, 1996.
9. Nakazato Y, Nakata Y, Mineta Y, et al. Acute performance of steroid-eluting screw-in leads for atrial free wall pacing. Jpn Circ J 63: 514-516, 1999.
10. Babbs C, Smith A, Hunt LP, Rowan BP, Haboubi NY, Warnes TW. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Lancet 1: 1021-1024, 1988.
11. Bonnet J, Garderes PE, Aumailley M, et al. Serum type III procollagen peptide levels in coronary artery disease (a marker of atherosclerosis). Eur J Clin Invest 18: 18-21, 1988.
12. Jensen LT, Horslev-Petersen K, Toft P, et al. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation 81: 52-57, 1990.
13. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91: 1450-1456, 1995.
14. Nobuoka S, Fujimaki R, Nagashima J, et al. Clinical significance of serum concentration of procollagen type III amino terminal peptide in patients with hypertensive left ventricular hypertrophy. Jpn J Appl Physiol 29: 287-292, 1999 (in Japanese, Abstract in English).